Form 4: Cellebrite DI Director Receives Stock Grant
Insider Transaction (Form 4)
Ryusuke Utsumi, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.
Summary
- Grant/award: acquired 15,190 Ordinary shares, par value NIS 0.00001 on September 17, 2026; holds 66,586 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ryusuke Utsumi — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Grant/award | Ordinary shares, par value NIS 0.00001 | 15,190 | — | — | 66,586 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Grant/award (15,190 shares) |
Keywords
insider transaction, Form 4, CLBT, Cellebrite DI Ltd., neutral, Ryusuke Utsumi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.